Jove
Visualize
Contact Us

Related Concept Videos

Protein Networks02:26

Protein Networks

4.6K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.6K
Protein Networks02:26

Protein Networks

2.9K
2.9K
Factors Affecting Protein-Drug Binding: Drug Interactions01:23

Factors Affecting Protein-Drug Binding: Drug Interactions

617
Drug interactions are a critical aspect of pharmacology and can occur when two or more drugs compete for the same binding site. This competition can result in one drug displacing another, altering the effect of the displaced drug. Drug interactions are complex processes that rely heavily on how much of the displacer drug is present and how strongly it can bind to the same sites as the displaced drug.
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
617
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

7.4K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.4K
Bioavailability Enhancement: Drug Solubility Enhancement01:16

Bioavailability Enhancement: Drug Solubility Enhancement

273
Body:Bioavailability is a critical factor in determining a drug's effectiveness. It refers to the proportion of a drug that enters the circulation when introduced into the body and is, as a result, able to have an active effect. Enhancing bioavailability is essential for drugs with poor solubility, as it can significantly impact their therapeutic efficacy. Various methods are employed to increase the solubility of drugs, thereby enhancing their bioavailability.Micronization and nanonization are...
273
Bioavailability Enhancement: Drug Permeability Enhancement01:27

Bioavailability Enhancement: Drug Permeability Enhancement

213
Body:After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt...
213

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

QSAR modelling of pesticide modes of toxic action across trophic levels via multi-label extreme gradient boosting.

Pest management science·2026
Same author

Quantifying tolerances or maximum residue limits of pesticide in food commodities via deep neural networks.

Pest management science·2025
Same author

Unravelling patterns of food tolerance to pesticide residues via non-negative matrix factorization.

Journal of food science·2025
Same author

Neglog: Homology-Based Negative Data Sampling Method for Genome-Scale Reconstruction of Human Protein-Protein Interaction Networks.

International journal of molecular sciences·2019
Same author

A Multi-Label Learning Framework for Drug Repurposing.

Pharmaceutics·2019
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Feb 12, 2026

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
13:18

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma

Published on: March 3, 2023

1.8K

In Silico Enhancing M. tuberculosis Protein Interaction Networks in STRING To Predict Drug-Resistance Pathways and

Suyu Mei1

  • 1Software College , Shenyang Normal University , Shenyang 110034 , China.

Journal of Proteome Research
|April 4, 2018
PubMed
Summary
This summary is machine-generated.

This study enhances bacterial protein-protein interaction (PPI) networks for Mycobacterium tuberculosis (MTB) using validated experimental data. The improved networks reveal drug-resistance pathways and potential drug targets, aiding in the development of safer therapeutics.

Keywords:
M. tuberculosis H37Rvdrug resistancemachine learningprotein−protein interaction networkssignaling pathwayssystem pharmacology

More Related Videos

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
11:06

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Published on: April 7, 2023

2.8K
A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
13:34

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

Published on: April 6, 2016

10.7K

Related Experiment Videos

Last Updated: Feb 12, 2026

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
13:18

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma

Published on: March 3, 2023

1.8K
Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
11:06

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Published on: April 7, 2023

2.8K
A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
13:34

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

Published on: April 6, 2016

10.7K

Area of Science:

  • Microbiology
  • Bioinformatics
  • Systems Biology

Background:

  • Bacterial protein-protein interaction (PPI) networks are crucial for understanding bacterial cell machinery, including signal transduction and drug resistance.
  • Existing databases like STRING contain numerous bacterial PPI networks, but many lack experimental validation, limiting their biomedical utility.
  • High-quality PPI networks are essential for identifying drug targets and understanding resistance mechanisms in pathogens like Mycobacterium tuberculosis (MTB).

Purpose of the Study:

  • To enhance the quality of MTB PPI networks in the STRING database by exploiting experimental data.
  • To validate MTB PPI networks using reliable experimental approaches and computational models.
  • To analyze drug-resistance pathways, identify potential cotarget and essential drug-target genes, and assess pharmacological risks by integrating human PPI networks.

Main Methods:

  • Four solutions were employed to enhance the quality of MTB PPI networks using experimental data.
  • An L2-regularized logistic regression model was trained using validated experimental data from two-hybrid and copurification approaches for network validation.
  • Breadth-first graph search algorithm and network degree distribution analysis were used to identify pathways and essential genes.
  • Validated MTB PPI networks were combined with human PPI networks for system pharmacology analysis.

Main Results:

  • Experimental data from two-hybrid and copurification approaches proved most reliable for validating MTB PPI networks.
  • The validated networks facilitated the discovery of MTB drug-resistance pathways and the identification of critical cotarget and essential drug-target genes.
  • Integration with human PPI networks revealed potential pharmacological risks, indicating that drugs targeting MTB genes might adversely affect human signaling pathways.

Conclusions:

  • Validated bacterial PPI networks are essential for accurate identification of drug targets and resistance mechanisms.
  • The study provides a robust framework for analyzing bacterial PPI networks, leading to the discovery of novel therapeutic strategies.
  • Cross-species PPI network analysis is vital for predicting and mitigating off-target effects of drugs, ensuring safer pharmacological interventions.